Schonfeld Strategic Advisors LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 241 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$258,727
-86.0%
36,751
-87.9%
0.00%
-88.9%
Q1 2023$1,848,384
-71.0%
302,518
-69.7%
0.02%
-66.0%
Q4 2022$6,377,859
+284.7%
998,100
+476.3%
0.05%
+278.6%
Q3 2022$1,658,000
-26.6%
173,183
+89.0%
0.01%
-39.1%
Q3 2021$2,260,000
+845.6%
91,641
+896.1%
0.02%
+666.7%
Q2 2021$239,000
-74.4%
9,200
-68.8%
0.00%
-72.7%
Q1 2021$935,000
+141.6%
29,501
+254.1%
0.01%
+120.0%
Q4 2020$387,000
-76.9%
8,332
-83.7%
0.01%
-84.4%
Q3 2020$1,678,000
-29.5%
50,969
-41.2%
0.03%0.0%
Q2 2020$2,380,000
+555.6%
86,718
+614.6%
0.03%
+39.1%
Q1 2020$363,000
-94.2%
12,135
-94.7%
0.02%
-85.0%
Q4 2019$6,278,000
+141.8%
226,851
+59.1%
0.15%
+101.3%
Q3 2019$2,596,000
+435.3%
142,600
+620.2%
0.08%
+347.1%
Q2 2019$485,000
-73.0%
19,800
-89.5%
0.02%
-72.6%
Q1 2019$1,793,000
-78.4%
188,430
-79.9%
0.06%
-80.6%
Q4 2018$8,304,000
+1564.1%
938,300
+3076.3%
0.32%
+762.2%
Q1 2018$499,000
+99.6%
29,541
-13.2%
0.04%
+42.3%
Q2 2017$250,00034,0240.03%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Perceptive Advisors 12,201,261$203,150,0004.07%
Paradigm Biocapital Advisors LP 907,428$15,109,0004.00%
Avoro Capital Advisors LLC 9,125,000$151,931,0002.77%
Logos Global Management LP 1,000,000$16,650,0002.16%
Avidity Partners Management LP 6,043,219$100,620,0002.10%
Orbimed Advisors 6,633,006$110,440,0001.79%
Parametrica Management Ltd 134,679$2,240,0001.66%
Boxer Capital, LLC 1,935,133$32,220,0001.66%
Fairmount Funds Management LLC 389,588$6,487,0001.53%
Long Focus Capital Management, LLC 705,000$11,738,0001.51%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders